Convergence of the two pandemics: metabolic syndrome and COVID-19 over last two years
has posed unprecedented challenges to individuals as well as healthcare systems …

D-dimer containing species are soluble fibrin degradation products derived from plasmin-
mediated degradation of cross-linked fibrin, ie,'D-dimer'. D-dimer can hence be considered a …

Elevated D-dimer plasma concentrations are common in hospitalized COVID-19 patients
and are often associated with a worse prognosis, but it is not yet clear whether this also …

Although nearly a fifth of symptomatic COVID-19 patients suffers from severe pulmonary
inflammation, the mechanism of developing severe illness is not yet fully understood. To …

Background: Therapeutic/intermediate-dose heparin reduces the risk of thromboembolic
events but increases the risk of major bleeding in patients hospitalized for acute COVID-19 …

Background Regulated breathing facilitates ventilation and reduces breathlessness.
However, the effect of Yogic breathing on patients with COVID remains unclear. We aimed to …

The rate of venous thromboembolism in COVID-19 patients has been reported to be
30%(deep vein thrombosis 20% and pulmonary embolism 18%). This has been shown to be …

Background COVID-19 was declared a global pandemic in March 2020. Early reports were
primarily in adults, and sickle cell disease (SCD) was classified as a risk factor for severe …

Background The influence of obesity on the development of thrombosis and severity of
coronavirus disease 2019 (COVID-19) remains unclear. Method The CLOT-COVID study …

Severe COVID-19 infections are at high risk of causing thromboembolic events (TEEs).
However, the usual exams may be unavailable or unreliable in predicting the risk of TEEs at …